Brief: Netscientific Says PDS Biotechnology Announces Achievement Of Efficacy Threshold in Stage 2 of VERSATILE-002 Trial Evaluating PDS0101 and Keytruda
14/06/2023 18:33
June 14 (Reuters) - Netscientific PLC NSCI.L :
* NETSCIENTIFIC PLC - PDS ANNOUNCES ACHIEVEMENT OF EFFICACY
THRESHOLD
* NETSCIENTIFIC - 14 PATIENTS IN IMMUNE CHECKPOINT INHIBITOR
NAÏVE
ARM OF VERSATILE-002 SAW COMPLETE RESPONSE OR PARTIAL RESPONSE
ON 2 CONSECUTIVE SCANS
Source text for Eikon: urn:newsml:reuters.com:*:nRSN7448Ca
Further company coverage: NSCI.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PDS Biotechnology
See all newsPDS Biotechnology Corp reports results for the quarter ended September 30 - Earnings Summary
PDS Biotechnology Q3 net loss narrows on lower R&D costs
PDS Biotechnology Corp expected to post a loss of 10 cents a share - Earnings Preview
Brief: PDS Biotech Announces Initial Closing Of Up To $22.3 Mln PIPE Financing
Brief: Pds Biotechnology Corp - On Aug 6, Approved Reduction In Force To Align Expenses With Strategic Priorities - SEC Filing